Fábio Beltrame Sanchez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fábio Beltrame Sanchez has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Kaio Jia Bin
Instituto de Medicina Física e Reabilitação, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
4 shared publications - Linamara Rizzo Battistella
Universidade de São Paulo
4 shared publications - Lucas Ramos De Pretto
Instituto de Medicina Física e Reabilitação, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
4 shared publications - Fabio Pacheco Muniz De Souza e Castro
Instituto de Medicina Física e Reabilitação, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
2 shared publications - Vinicius Delgado Ramos
Universidade de São Paulo, Brasil
2 shared publications
Latest Publications
- Open Access
- 12 September 2023
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 7 (1) , e47388
Digital Platform for Continuous Monitoring of Patients Using a Smartwatch: Longitudinal Prospective Cohort Study
Background: Since the COVID-19 pandemic, there has been a boost in the digital transformation of the human society, where wearable devices such as a smartwatch can already measure vital signs in a continuous and naturalistic way; however, the security and privacy of personal data is a challenge to expanding the use of these data by health professionals in clinical follow-up for decision-making. Similar to the European General Data Protection Regulation, in Brazil, the Lei Geral de Proteção de Dados established rules and guidelines for the processing of personal data, including those used for patient care, such as those captured by smartwatches. Thus, in any telemonitoring scenario, there is a need to comply with rules and regulations, making this issue a challenge to overcome. Objective: This study aimed to build a digital solution model for capturing data from wearable devices and making them available in a safe and agile manner for clinical and research use, following current laws. Methods: A functional model was built following the Brazilian Lei Geral de Proteção de Dados (2018), where data captured by smartwatches can be transmitted anonymously over the Internet of Things and be identified later within the hospital. A total of 80 volunteers were selected for a 24-week follow-up clinical trial divided into 2 groups, one group with a previous diagnosis of COVID-19 and a control group without a previous diagnosis of COVID-19, to measure the synchronization rate of the platform with the devices and the accuracy and precision of the smartwatch in out-of-hospital conditions to simulate remote monitoring at home. Results: In a 35-week clinical trial, >11.2 million records were collected with no system downtime; 66% of continuous beats per minute were synchronized within 24 hours (79% within 2 days and 91% within a week). In the limit of agreement analysis, the mean differences in oxygen saturation, diastolic blood pressure, systolic blood pressure, and heart rate were −1.280% (SD 5.679%), −1.399 (SD 19.112) mm Hg, −1.536 (SD 24.244) mm Hg, and 0.566 (SD 3.114) beats per minute, respectively. Furthermore, there was no difference in the 2 study groups in terms of data analysis (neither using the smartwatch nor the gold-standard devices), but it is worth mentioning that all volunteers in the COVID-19 group were already cured of the infection and were highly functional in their daily work life. Conclusions: On the basis of the results obtained, considering the validation conditions of accuracy and precision and simulating an extrahospital use environment, the functional model built in this study is capable of capturing data from the smartwatch and anonymously providing it to health care services, where they can be treated according to the legislation and be used to support clinical decisions during remote monitoring.
- 12 September 2023
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 7 (1) , e47388
Open AccessDigital Platform for Continuous Monitoring of Patients Using a Smartwatch: Longitudinal Prospective Cohort Study
Background: Since the COVID-19 pandemic, there has been a boost in the digital transformation of the human society, where wearable devices such as a smartwatch can already measure vital signs in a continuous and naturalistic way; however, the security and privacy of personal data is a challenge to expanding the use of these data by health professionals in clinical follow-up for decision-making. Similar to the European General Data Protection Regulation, in Brazil, the Lei Geral de Proteção de Dados established rules and guidelines for the processing of personal data, including those used for patient care, such as those captured by smartwatches. Thus, in any telemonitoring scenario, there is a need to comply with rules and regulations, making this issue a challenge to overcome. Objective: This study aimed to build a digital solution model for capturing data from wearable devices and making them available in a safe and agile manner for clinical and research use, following current laws. Methods: A functional model was built following the Brazilian Lei Geral de Proteção de Dados (2018), where data captured by smartwatches can be transmitted anonymously over the Internet of Things and be identified later within the hospital. A total of 80 volunteers were selected for a 24-week follow-up clinical trial divided into 2 groups, one group with a previous diagnosis of COVID-19 and a control group without a previous diagnosis of COVID-19, to measure the synchronization rate of the platform with the devices and the accuracy and precision of the smartwatch in out-of-hospital conditions to simulate remote monitoring at home. Results: In a 35-week clinical trial, >11.2 million records were collected with no system downtime; 66% of continuous beats per minute were synchronized within 24 hours (79% within 2 days and 91% within a week). In the limit of agreement analysis, the mean differences in oxygen saturation, diastolic blood pressure, systolic blood pressure, and heart rate were −1.280% (SD 5.679%), −1.399 (SD 19.112) mm Hg, −1.536 (SD 24.244) mm Hg, and 0.566 (SD 3.114) beats per minute, respectively. Furthermore, there was no difference in the 2 study groups in terms of data analysis (neither using the smartwatch nor the gold-standard devices), but it is worth mentioning that all volunteers in the COVID-19 group were already cured of the infection and were highly functional in their daily work life. Conclusions: On the basis of the results obtained, considering the validation conditions of accuracy and precision and simulating an extrahospital use environment, the functional model built in this study is capable of capturing data from the smartwatch and anonymously providing it to health care services, where they can be treated according to the legislation and be used to support clinical decisions during remote monitoring.
- Open Access
- 17 March 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Digital Platform for Continuous Monitoring of Patients Using a Smartwatch: Longitudinal Prospective Cohort Study (Preprint)
BACKGROUND Since the COVID-19 pandemic, there has been a boost in the digital transformation of the human society, where wearable devices such as a smartwatch can already measure vital signs in a continuous and naturalistic way; however, the security and privacy of personal data is a challenge to expanding the use of these data by health professionals in clinical follow-up for decision-making. Similar to the European General Data Protection Regulation, in Brazil, the Lei Geral de Proteção de Dados established rules and guidelines for the processing of personal data, including those used for patient care, such as those captured by smartwatches. Thus, in any telemonitoring scenario, there is a need to comply with rules and regulations, making this issue a challenge to overcome. OBJECTIVE This study aimed to build a digital solution model for capturing data from wearable devices and making them available in a safe and agile manner for clinical and research use, following current laws. METHODS A functional model was built following the Brazilian Lei Geral de Proteção de Dados (2018), where data captured by smartwatches can be transmitted anonymously over the Internet of Things and be identified later within the hospital. A total of 80 volunteers were selected for a 24-week follow-up clinical trial divided into 2 groups, one group with a previous diagnosis of COVID-19 and a control group without a previous diagnosis of COVID-19, to measure the synchronization rate of the platform with the devices and the accuracy and precision of the smartwatch in out-of-hospital conditions to simulate remote monitoring at home. RESULTS In a 35-week clinical trial, >11.2 million records were collected with no system downtime; 66% of continuous beats per minute were synchronized within 24 hours (79% within 2 days and 91% within a week). In the limit of agreement analysis, the mean differences in oxygen saturation, diastolic blood pressure, systolic blood pressure, and heart rate were −1.280% (SD 5.679%), −1.399 (SD 19.112) mm Hg, −1.536 (SD 24.244) mm Hg, and 0.566 (SD 3.114) beats per minute, respectively. Furthermore, there was no difference in the 2 study groups in terms of data analysis (neither using the smartwatch nor the gold-standard devices), but it is worth mentioning that all volunteers in the COVID-19 group were already cured of the infection and were highly functional in their daily work life. CONCLUSIONS On the basis of the results obtained, considering the validation conditions of accuracy and precision and simulating an extrahospital use environment, the functional model built in this study is capable of capturing data from the smartwatch and anonymously providing it to health care services, where they can be treated according to the legislation and be used to support clinical decisions during remote monitoring.
- 17 March 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDigital Platform for Continuous Monitoring of Patients Using a Smartwatch: Longitudinal Prospective Cohort Study (Preprint)
BACKGROUND Since the COVID-19 pandemic, there has been a boost in the digital transformation of the human society, where wearable devices such as a smartwatch can already measure vital signs in a continuous and naturalistic way; however, the security and privacy of personal data is a challenge to expanding the use of these data by health professionals in clinical follow-up for decision-making. Similar to the European General Data Protection Regulation, in Brazil, the Lei Geral de Proteção de Dados established rules and guidelines for the processing of personal data, including those used for patient care, such as those captured by smartwatches. Thus, in any telemonitoring scenario, there is a need to comply with rules and regulations, making this issue a challenge to overcome. OBJECTIVE This study aimed to build a digital solution model for capturing data from wearable devices and making them available in a safe and agile manner for clinical and research use, following current laws. METHODS A functional model was built following the Brazilian Lei Geral de Proteção de Dados (2018), where data captured by smartwatches can be transmitted anonymously over the Internet of Things and be identified later within the hospital. A total of 80 volunteers were selected for a 24-week follow-up clinical trial divided into 2 groups, one group with a previous diagnosis of COVID-19 and a control group without a previous diagnosis of COVID-19, to measure the synchronization rate of the platform with the devices and the accuracy and precision of the smartwatch in out-of-hospital conditions to simulate remote monitoring at home. RESULTS In a 35-week clinical trial, >11.2 million records were collected with no system downtime; 66% of continuous beats per minute were synchronized within 24 hours (79% within 2 days and 91% within a week). In the limit of agreement analysis, the mean differences in oxygen saturation, diastolic blood pressure, systolic blood pressure, and heart rate were −1.280% (SD 5.679%), −1.399 (SD 19.112) mm Hg, −1.536 (SD 24.244) mm Hg, and 0.566 (SD 3.114) beats per minute, respectively. Furthermore, there was no difference in the 2 study groups in terms of data analysis (neither using the smartwatch nor the gold-standard devices), but it is worth mentioning that all volunteers in the COVID-19 group were already cured of the infection and were highly functional in their daily work life. CONCLUSIONS On the basis of the results obtained, considering the validation conditions of accuracy and precision and simulating an extrahospital use environment, the functional model built in this study is capable of capturing data from the smartwatch and anonymously providing it to health care services, where they can be treated according to the legislation and be used to support clinical decisions during remote monitoring.
- Open Access
- 15 September 2022
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 6 (9) , e40468
Digital Platform to Continuously Monitor Patients Using a Smartwatch: Preliminary Report
Background: Monitoring vital signs such as oximetry, blood pressure, and heart rate is important to follow the evolution of patients. Smartwatches are a revolution in medicine allowing the collection of such data in a continuous and organic way. However, it is still a challenge to make this information available to health care professionals to make decisions during clinical follow-up. Objective: This study aims to build a digital solution that displays vital sign data from smartwatches, collected remotely, continuously, reliably, and from multiple users, with trigger warnings when abnormal results are identified. Methods: This is a single-center prospective study following the guidelines “Evaluating digital health products” from the UK Health Security Agency. A digital platform with 3 different applications was created to capture and display data from the mobile phones of volunteers with smartwatches. We selected 80 volunteers who were followed for 24 weeks each, and the synchronization interval between the smartwatch and digital solution was recorded for each vital sign collected. Results: In 14 weeks of project progress, we managed to recruit 80 volunteers, with 68 already registered in the digital solution. More than 2.8 million records have already been collected, without system downtime. Less than 5% of continuous heart rate measurements (bpm) were synchronized within 2 hours. However, approximately 70% were synchronized in less than 24 hours, and 90% were synchronized in less than 119 hours. Conclusions: The digital solution is working properly in its role of displaying data collected from smartwatches. Vital sign values are being monitored by the research team as part of the monitoring of volunteers. Although the digital solution proved unsuitable for monitoring urgent events, it is more than suitable for use in outpatient clinical use. This digital solution, which is based on cloud technology, can be applied in the future for telemonitoring in regions lacking health care professionals. Accuracy and reliability studies still need to be performed at the end of the 24-week follow-up.
- 15 September 2022
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 6 (9) , e40468
Open AccessDigital Platform to Continuously Monitor Patients Using a Smartwatch: Preliminary Report
Background: Monitoring vital signs such as oximetry, blood pressure, and heart rate is important to follow the evolution of patients. Smartwatches are a revolution in medicine allowing the collection of such data in a continuous and organic way. However, it is still a challenge to make this information available to health care professionals to make decisions during clinical follow-up. Objective: This study aims to build a digital solution that displays vital sign data from smartwatches, collected remotely, continuously, reliably, and from multiple users, with trigger warnings when abnormal results are identified. Methods: This is a single-center prospective study following the guidelines “Evaluating digital health products” from the UK Health Security Agency. A digital platform with 3 different applications was created to capture and display data from the mobile phones of volunteers with smartwatches. We selected 80 volunteers who were followed for 24 weeks each, and the synchronization interval between the smartwatch and digital solution was recorded for each vital sign collected. Results: In 14 weeks of project progress, we managed to recruit 80 volunteers, with 68 already registered in the digital solution. More than 2.8 million records have already been collected, without system downtime. Less than 5% of continuous heart rate measurements (bpm) were synchronized within 2 hours. However, approximately 70% were synchronized in less than 24 hours, and 90% were synchronized in less than 119 hours. Conclusions: The digital solution is working properly in its role of displaying data collected from smartwatches. Vital sign values are being monitored by the research team as part of the monitoring of volunteers. Although the digital solution proved unsuitable for monitoring urgent events, it is more than suitable for use in outpatient clinical use. This digital solution, which is based on cloud technology, can be applied in the future for telemonitoring in regions lacking health care professionals. Accuracy and reliability studies still need to be performed at the end of the 24-week follow-up.
- Open Access
- 22 June 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Digital platform for remote monitoring of patient using a smartwatch (Preprint)
BACKGROUND Vital signs monitoring such as oximetry, blood pressure and heart rate are important to follow-up the evolution of patients, alerting the need for clinical intervention and adjustments in the therapeutic process, avoiding worsening of the clinical picture, new hospitalizations and the expansion of the disabling condition. And the possibility of measuring continuously and naturally through wearable devices, such as smart watches, is a revolution in medicine through mobile health (m-health) and digital health (e-health). OBJECTIVE Build a digital solution that captures vital signs data from smart watches in a continuous, secure and reliable way. METHODS This is a single-centre prospective study following the guidelines “Evaluating digital health products” from UK Health Security Agency. A digital solution was created to capture and display data from mobile phone of the volunteers with the smartwatches. 80 volunteers were selected for this clinical trial, divided by the previous diagnosis of Covid-19 in two groups, and are followed by 24 weeks each. RESULTS In 14 weeks of project progress, we managed to recruit 80 volunteers, with 68 already registered in the digital solution. More than 2.8 million records have already been collected. CONCLUSIONS The digital solution is working properly in its role of collecting data from the smart watches of research volunteers. Vital sign values are being monitored by the research team as part of monitoring the health of volunteers. Accuracy and reliability studies still need to be performed at the end of the 24-week follow-up of volunteers. CLINICALTRIAL This project was submitted to the Ethics and Research Committee of the Hospital das Clínicas, Faculty of Medicine, University of São Paulo under number CAAE: 51711921.3.0000.0068 and Opinion No. 4,975,512. Its opinion was approved on September 15, 2021 without the need for consideration by CONEP.
- 22 June 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDigital platform for remote monitoring of patient using a smartwatch (Preprint)
BACKGROUND Vital signs monitoring such as oximetry, blood pressure and heart rate are important to follow-up the evolution of patients, alerting the need for clinical intervention and adjustments in the therapeutic process, avoiding worsening of the clinical picture, new hospitalizations and the expansion of the disabling condition. And the possibility of measuring continuously and naturally through wearable devices, such as smart watches, is a revolution in medicine through mobile health (m-health) and digital health (e-health). OBJECTIVE Build a digital solution that captures vital signs data from smart watches in a continuous, secure and reliable way. METHODS This is a single-centre prospective study following the guidelines “Evaluating digital health products” from UK Health Security Agency. A digital solution was created to capture and display data from mobile phone of the volunteers with the smartwatches. 80 volunteers were selected for this clinical trial, divided by the previous diagnosis of Covid-19 in two groups, and are followed by 24 weeks each. RESULTS In 14 weeks of project progress, we managed to recruit 80 volunteers, with 68 already registered in the digital solution. More than 2.8 million records have already been collected. CONCLUSIONS The digital solution is working properly in its role of collecting data from the smart watches of research volunteers. Vital sign values are being monitored by the research team as part of monitoring the health of volunteers. Accuracy and reliability studies still need to be performed at the end of the 24-week follow-up of volunteers. CLINICALTRIAL This project was submitted to the Ethics and Research Committee of the Hospital das Clínicas, Faculty of Medicine, University of São Paulo under number CAAE: 51711921.3.0000.0068 and Opinion No. 4,975,512. Its opinion was approved on September 15, 2021 without the need for consideration by CONEP.